We could not find any results for:
Make sure your spelling is correct or try broadening your search.
| Ticker | Name | Price | Change | Change % | Volume |
|---|---|---|---|---|---|
HTCO | High Trend International Group | 32.501 | 21.25 | 188.90% | 12,277,648 |
YAAS | Youxin Technology Ltd | 1.87 | 0.9406 | 101.21% | 140,191,644 |
EDSA | Edesa Biotech Inc | 11.0299 | 3.77 | 51.93% | 8,212,846 |
SEGG | Sports Entertainment Gaming Global Corporation | 0.9248 | 0.2698 | 41.19% | 5,032,915 |
CAST | FreeCast Inc | 2.97 | 0.84 | 39.44% | 4,826,036 |
SGMT | Sagimet Biosciences Inc | 7.9509 | 2.09 | 35.68% | 47,565,043 |
CRMU | Leverage Shares 2X Long CRML Daily ETF | 13.20 | 3.45 | 35.38% | 376,993 |
ONCO | Onconetix Inc | 0.7763 | 0.1888 | 32.14% | 90,440,657 |
SPRC | SciSparc Ltd | 8.785 | 2.10 | 31.32% | 205,088 |
QNTM | Quantum Biopharma Ltd | 4.695 | 1.09 | 30.06% | 1,778,146 |
JSPRW | Jasper Therapeutics Inc | 0.0199 | 0.0044 | 28.38% | 21,926 |
The Real Brokerage Inc. (NASDAQ: REAX) (“Real”), a leading technology-powered real estate brokerage, and RE/MAX Holdings, Inc. (NYSE: RMAX) (“RE/MAX Holdings”), the parent company of RE/MAX, LLC (“REMAX”), one of the world’s leading franchisors of real estate brokerage services, today announced that they have entered into a definitive agreement under which Real will acquire RE/MAX Holdings to create a leading technology-enabled global real estate platform named Real REMAX Group. The transaction implies an enterprise value for RE/MAX Holdings of approximately $880 million, representing a fully synergized multiple of 7x 2025 EBITDA. The transaction is expected to be accretive to Real’s ...
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported six month results from its FULCRUM-VT Investigational Device Exemption (“IDE”) clinical trial, which will be used to support the Company’s application for Food and Drug Administration (“FDA”) Premarket Approval of the vCLAS Ventricular Ablation System. The results were presented today in a late-breaking clinical trial session at the Heart Rhythm Society 2026 conference.
XIAMEN, China, April 24, 2026 /PRNewswire/ -- Hitek Global Inc. (Nasdaq: HKIT) (the "Company"), a China-based information technology consulting and solutions service provider, today announced its financial results for the fiscal year ended December 31, 2025.
X-energy, Inc. (“X-energy”), a leader in advanced nuclear reactor and fuel technology, today announced the pricing of its upsized initial public offering (“IPO”) of 44,254,659 shares of its Class A common stock at a public offering price of $23.00 per share. In connection with the offering, X-energy has granted the underwriters a 30-day option to purchase up to an additional 6,638,198 shares of Class A common stock.
| Rank | Ticker | Board Name | Posts (24h) |
|---|---|---|---|
| FNMA | Fannie Mae-No Politics | ||
| RKT | Rocket Companies Inc | ||
| HIRU | Hiru Corporation | ||
| 4 | AVXL | Anavex Life Sciences Corp | |
| 5 | AMRN | Amarin Corp Plc | |
| 6 | NLST | NetList Inc |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions